Abbott India Share Price, Stock Analysis & Company Overview

Abbott India Limited is one of India's fastest-growing and most respected pharmaceutical companies, operating as a subsidiary of the global healthcare leader, Abbott Laboratories. As a prominent name in the Pharmaceuticals & Drugs Sector, the company is dedicated to helping people in India live healthier lives through a diverse range of science-based nutritional products, diagnostic tools, and branded generic pharmaceuticals. Headquartered in Mumbai, Abbott India maintains a leadership position across multiple therapeutic categories.

This page provides investors with a comprehensive view to monitor the Abbott India share price, conduct a detailed Abbott India stock analysis, and evaluate the company’s extensive portfolio of trusted healthcare brands.

About Abbott India Limited

Established in India over a century ago, Abbott India has built a legacy of trust and quality. The company offers over 600 products in various therapeutic areas, including women’s health, gastroenterology, cardiology, metabolic disorders, and primary care.

Unlike many other pharmaceutical players that focus heavily on exports, Abbott India has a dominant focus on the domestic Indian market. Its strength lies in its powerful brands, such as Duphaston, Thyronorm, and Udiliv, which are household names among medical practitioners and patients alike.

Abbott India Business Model

The company operates a science-led business model that combines global research with local manufacturing and distribution expertise. Key operational pillars include:

• Branded Generics: Offering high-quality, reliable medicines that are affordable and tailored to the unique needs of the Indian population.

• Specialty Care: Focusing on high-growth segments like Gastroenterology, Hepatic Care, and Hormones.

• Women's Health & Maternal Nutrition: Providing specialised solutions for pregnancy, menopause, and neonatal care.

• Consumer Health: Managing a portfolio of over-the-counter (OTC) products that address common health needs.

• Innovation & Development: Leveraging in-house medical teams to develop high-volume formulations using cost-efficient, international quality-standard processes.

Abbott India IPO and Listing Details

Abbott India is a premium large-cap stock, recognised for its low volatility and steady wealth creation for long-term shareholders.

• Listing Exchanges: NSE and BSE
• Face Value: Rs 10 per share
• ISIN: INE358A01014
• NSE Symbol: ABBOTINDIA
• BSE Scrip Code: 500488

Abbott India Corporate Action History

The company is widely regarded for its conservative capital structure and its commitment to returning value to its investors.

Dividend History

Abbott India is a standout "dividend stock" in the pharma space, often rewarding shareholders with significant annual payouts.

• FY 2025-26: Expected dividend of Rs 475.00 per share (Record Date: July 2026).

• FY 2024-25: Declared a final dividend of Rs 475.00 per share.

• FY 2023-24: Declared a final dividend of Rs 410.00 per share.

• Trend: The company has a 10-year dividend growth rate of approximately 30%, reflecting its strong cash-generation capabilities.

Investor Resources Available on This Page

Retail investors can access several features in the respective tables on this page to conduct a professional Abbott India stock analysis:

• Price Chart: Track the steady, long-term growth and historical performance of the Abbott India share price. (data delayed by 15 minutes)

• Company Ratios: Review critical metrics like Return on Equity (ROE), ROCE, and the current Dividend Yield.

• Quarterly Results: Monitor revenue growth and net profit margins across different therapeutic segments.

• Balance Sheet: Analyse the company’s zero-debt status and its massive cash reserves.

• Cash Flow Statement: Evaluate how efficiently the company converts its domestic sales into free cash flow.

• Shareholding & Promoters: Track the stake held by the parent company, Abbott Capital India Ltd, and institutional investors.

• Pros & Cons: A simplified summary of the company’s brand power versus regulatory risks in the domestic market.

• Annual Reports: Download official documents for deep insights into the company’s therapeutic focus and product pipeline.

Want to filter out stocks using your own financial benchmarks? You can use the Stock Screener on Finology Ticker to identify and compare companies based on specific growth and efficiency metrics

Frequently Asked Questions (FAQs)

Q1. What is the latest Abbott India share price?

The current price is displayed at the top of this page. Please note that all price data and charts are provided with a 15-minute delay from the exchanges.

Q2. Who are the promoters of Abbott India?

Abbott India is a subsidiary of Abbott Laboratories, USA. The promoter entity, Abbott Capital India Limited, holds a majority stake in the company.

Q3. What are the top-selling brands of Abbott India?

Some of its most famous brands include Thyronorm (for thyroid), Udiliv (for liver care), Duphaston (women's health), and Digene (antacid).

Q4. Does Abbott India pay regular dividends?

Yes, Abbott India is known for its high dividend payouts. In 2025, it declared a significant dividend of Rs 475 per share.

Q5. Where can I find Abbott India's quarterly results?

All quarterly performance data, including net sales and profit after tax (PAT), is updated in the "Quarterly Results" table on this page.

Q6. How can I download the Abbott India Annual Report?

The latest and historical Annual Reports can be downloaded directly from the "Reports" or "Documents" section table provided on this page.